Home-based resistance exercise program for adults after cancer treatment
Comparing the Health Benefits of Digital Home-based Resistance Exercise and Supervised On-site Resistance Exercise in Cancer Patients After Treatment - a 12 Week RCT.
NA · Inland Norway University of Applied Sciences · NCT07159815
This program tests whether 12 weeks of home-based digital resistance exercise helps adults who have finished cancer treatment improve physical function compared with on-site follow-up.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Inland Norway University of Applied Sciences (other) |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Lillehammer) |
| Trial ID | NCT07159815 on ClinicalTrials.gov |
What this trial studies
REACT compares a 12-week digital, home-based resistance exercise program with on-site follow-up for adults who have completed cancer treatment. Eligible participants receive a structured resistance exercise regimen delivered either through a digital platform run by the 'Active against cancer' network or via hospital-based sessions. The intervention focuses on improving strength, physical function, and adherence by offering remote access, scheduled sessions, and cancer-specific guidance. Key outcomes include functional performance and adherence measured over the 12-week intervention period.
Who should consider this trial
Good fit: Adults (≥18 years) who completed systemic or radiotherapy cancer treatment within the past 12 months (or are on stable oral maintenance), have a life expectancy >12 months, can use digital tools at home, and understand Norwegian.
Not a fit: Patients with serious cardiac, pulmonary, or other comorbidities that prohibit exercise, cancer-related conditions that prevent exercise, those undergoing high-risk active treatments causing severe bone marrow suppression, or those without digital access or Norwegian language ability may not benefit.
Why it matters
Potential benefit: If successful, this approach could make cancer rehabilitation more accessible and improve strength, function, and quality of life for survivors.
How similar studies have performed: Resistance exercise has previously improved strength and function after cancer, but evidence for digitally delivered home-based programs in this population is more limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years and able to give informed consent * Previously diagnosed with any form of cancer and completed systemic chemotherapy, immunotherapy or targeted therapies or local radiotherapy * Have completed active cancer treatment not more than 12 months earlier or at present undergoing oral home-based treatment for stabilization or other treatments of disease or to prevent relapse * Life expectancy of more than 12 months * Digital opportunities at home: e.g axcess to pc, and/or ipad, email adress to log on the platform * Able to understand Norwegian language Exclusion Criteria: * Co-morbidities prohibiting exercise according to protocol like serious cardic, pulmonary and other organ diseases * Conditions caused by the cancer which prohibits exercise like previous major surgery, fractures, pain * Still undergoing active cancer treatment that is expected to confer a high risk of bone marrow suppresion that would lead to infections, bleeding and/or severly reduced physical capacity * Life expectancy of less than 12 months * Reduced mental capacity and not able to give informed consent and follow the program * Travelling distance more than 20 km from home or workplace to the two exercise locations (Gjøvik and/or Lillehammer) for patients who are candidates for randomization
Where this trial is running
Lillehammer
- Inland Norway University of Applied Sciences — Lillehammer, Norway (RECRUITING)
Study contacts
- Study coordinator: Anne Mette Rustaden, PhD
- Email: anne.rustaden@inn.no
- Phone: +47 48100644
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer